Colorectal cancer is the third most common cancer worldwide, resulting in 50,000 deaths annually in the U.S. alone.

Now, new clinical trial results suggest that an oral form of this medication may be coming soon—and the results so far are ...

A Shropshire charity says it is ready to start clinical trials on a new drug to treat lung cancer. Although the charity ...

In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight ...

Men with prostate cancer could get access to life-saving trials within hours, under a programme to speed up access to ...

A two-drug combination for treating advanced kidney cancer has shown sustained and durable clinical benefit in more than five ...

In a major advance for patients with Crohn’s disease, a new study led by researchers at Mount Sinai Health System found that ...

Oral, non-opioid drug candidate advancing through Phase 1 and nearing completion of the single ascending dose (SAD) portion ...

Raytone Biotech has successfully treated the first patient in its clinical trial of RTP-008 for the treatment of dry eye ...

Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is ...

Less than one-quarter of next-in-class cancer drugs demonstrated a survival benefit over existing in-class agents in head-to-head trials.